Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Affimed N.V. (AFMD)

Affimed N.V. (AFMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 76,135
  • Shares Outstanding, K 15,227
  • Annual Sales, $ 8,960 K
  • Annual Income, $ -114,660 K
  • 60-Month Beta 2.05
  • Price/Sales 8.76
  • Price/Cash Flow N/A
  • Price/Book 1.21
Trade AFMD with:

Options Overview Details

View History
  • Implied Volatility 120.48% ( -2.48%)
  • Historical Volatility 85.79%
  • IV Percentile 18%
  • IV Rank 8.61%
  • IV High 1,342.71% on 11/14/23
  • IV Low 5.31% on 02/15/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 103
  • Volume Avg (30-Day) 44
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 3,143
  • Open Int (30-Day) 4,875

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -1.86
  • Number of Estimates 3
  • High Estimate -1.59
  • Low Estimate -2.28
  • Prior Year -2.30
  • Growth Rate Est. (year over year) +19.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.72 +13.35%
on 04/22/24
7.24 -26.10%
on 04/03/24
+0.36 (+7.21%)
since 03/22/24
3-Month
4.24 +26.03%
on 03/14/24
7.24 -26.10%
on 04/03/24
-0.47 (-8.08%)
since 01/23/24
52-Week
2.23 +139.37%
on 10/27/23
11.10 -51.80%
on 05/22/23
-3.15 (-37.03%)
since 04/21/23

Most Recent Stories

More News
Affimed N.V.: Q3 Earnings Snapshot

Affimed N.V.: Q3 Earnings Snapshot

AFMD : 5.35 (+7.00%)
Affimed N.V.: Q2 Earnings Snapshot

Affimed N.V.: Q2 Earnings Snapshot

AFMD : 5.35 (+7.00%)
Affimed N.V.: Q1 Earnings Snapshot

Affimed N.V.: Q1 Earnings Snapshot

AFMD : 5.35 (+7.00%)
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates

Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -7.14% and 98.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

CLSD : 1.3700 (-2.84%)
AFMD : 5.35 (+7.00%)
Exelixis (EXEL) Lags Q1 Earnings and Revenue Estimates

Exelixis (EXEL) delivered earnings and revenue surprises of -30.43% and 4.47%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

EXEL : 23.29 (+1.84%)
AFMD : 5.35 (+7.00%)
Affimed N.V. (AFMD) Reports Q4 Loss, Tops Revenue Estimates

Affimed N.V. (AFMD) delivered earnings and revenue surprises of -15.79% and 45.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AFMD : 5.35 (+7.00%)
NRIX : 14.13 (+4.05%)
Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Tops Revenue Estimates

Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of 47.06% and 46.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

LQDA : 12.95 (-1.75%)
AFMD : 5.35 (+7.00%)
Ikena Oncology, Inc. (IKNA) Reports Q4 Loss, Tops Revenue Estimates

Ikena Oncology, Inc. (IKNA) delivered earnings and revenue surprises of 26.42% and 67.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

IKNA : 1.3500 (+3.85%)
AFMD : 5.35 (+7.00%)
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of -54.55% and 3.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ANIK : 25.79 (-0.62%)
AFMD : 5.35 (+7.00%)
NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Tops Revenue Estimates

NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 13.46% and 166.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

NGM : 1.5400 (-1.28%)
AFMD : 5.35 (+7.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V.,...

See More

Key Turning Points

3rd Resistance Point 5.89
2nd Resistance Point 5.68
1st Resistance Point 5.51
Last Price 5.35
1st Support Level 5.13
2nd Support Level 4.92
3rd Support Level 4.75

See More

52-Week High 11.10
Fibonacci 61.8% 7.71
Fibonacci 50% 6.67
Fibonacci 38.2% 5.62
Last Price 5.35
52-Week Low 2.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar